Synthesis, characterization, crystal structure, α-glycosidase, and acetylcholinesterase inhibitory properties of 1,3-disubstituted benzimidazolium salts

dc.contributor.authorBal, Selma
dc.contributor.authorDemirci, Ozlem
dc.contributor.authorSen, Betul
dc.contributor.authorTaslimi, Parham
dc.contributor.authorAktas, Aydin
dc.contributor.authorGok, Yetkin
dc.contributor.authorAygun, Muhittin
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T13:23:12Z
dc.date.created2021
dc.date.issued2021
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractChloro-/fluorobenzyl-substituted benzimidazolium salts were synthesized from the reaction of 4-fluorobenzyl/2-chloro-4-fluorobenzyl-substituted benzimidazole and chlorinated aromatic hydrocarbons. They were characterized using various spectroscopic techniques (Fourier-transform infrared and nuclear magnetic resonance) and elemental analysis. In addition, the crystal structures of the complexes 1a -d and 2b were determined by single-crystal X-ray diffraction methods. These compounds were crystallized in the triclinic crystal system with a P-1 space group. The crystal packing of all complexes is dominated by O-HMIDLINE HORIZONTAL ELLIPSISCl hydrogen bonds, which link the water molecules and chloride anions, forming a chloride-water tetrameric cluster. These synthesized salts were found to be effective inhibitors for alpha-glycosidase and acetylcholinesterase (AChE), with K-i values ranging from 45.77 +/- 6.83 to 102.61 +/- 11.56 mu M for alpha-glycosidase and 0.94 +/- 0.14 to 10.24 +/- 1.58 mu M for AChE. AChE converts acetylcholine into choline and acetic acid, thus causing the return of a cholinergic neuron to its resting state. Discovering AChE and alpha-glycosidase inhibitors is one of the important ways to develop new drugs for the treatment of Alzheimer's disease and diabetes.
dc.description.sponsorshipInonu University Research Fund [FYL-2020-2279]; Kahramanmaras Sutcu Imam University Research Fund [FYL-2019/6-23 M]
dc.description.sponsorshipInonu University Research Fund, Grant/Award Number: FYL-2020-2279; Kahramanmaras Sutcu Imam University Research Fund, Grant/Award Number: FYL-2019/6-23 M
dc.identifier.doi10.1002/ardp.202000422
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184
dc.identifier.issue5
dc.identifier.orcidAygun, Muhittin/0000-0001-9670-9062
dc.identifier.orcidGulcin, ilhami/0000-0001-5993-1668
dc.identifier.pmid33427318
dc.identifier.scopus2-s2.0-85099085096
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1002/ardp.202000422
dc.identifier.urihttps://hdl.handle.net/11772/22738
dc.identifier.volume354
dc.identifier.wosWOS:000606534300001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofArchiv Der Pharmazie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectAcetylcholinesterase
dc.subjectAlpha-Glycosidase
dc.subjectBenzimidazolium Salts
dc.subjectCrystal Structure
dc.subjectFluorobenzyl Substituted
dc.titleSynthesis, characterization, crystal structure, α-glycosidase, and acetylcholinesterase inhibitory properties of 1,3-disubstituted benzimidazolium salts
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar